I-Mab Biopharma US
Organization
Trials
Phase 2, Recruiting, 180 people, Feb 25, 2026
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Phase 1, Recruiting, 330 people, May 25, 2021
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
Phase 1, Completed, 98 people, May 2, 2019
Sources: clinicaltrials.gov